CD4 and non-small cell lung carcinoma: Furthermore, single-cell sequencing of patients with stage IIIA NSCLC has demonstrated that the synergistic proliferation of B cells and CD4+ T cells is associated with a positive treatment response to neoadjuvant immunotherapy [29].